This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: University of California. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Elie J Diner: Innovator in Interferon Research
Introduction
Elie J Diner, a prominent inventor based in San Rafael, California, has made significant contributions to the field of biotechnology. With a focus on enhancing the production of type I interferon, his research has important implications for therapeutic applications in various diseases, particularly viral infections.
Latest Patents
Diner holds one patent titled "Cyclic di-nucleotide induction of type I interferon." This innovative patent encompasses methods and compositions that enhance the production of type I interferon (IFN) within a cell. Central to this invention is the utilization of a 2′-5′ phosphodiester linkage, specifically involving cyclic di-nucleotides, to effectively elevate the levels of IFN produced, thereby broadening the potential for new therapeutic strategies. The patent also includes compositions and kits designed for practical application of the disclosed methods.
Career Highlights
Elie J Diner is affiliated with the University of California, where he engages in cutting-edge research and development. His academic and professional journey has emphasized the importance of innovating methods that harness the body's immune responses, particularly through the modulation of interferons, which are crucial for antiviral and antitumoral defenses.
Collaborations
Throughout his career, Diner has collaborated with notable colleagues such as Russell E Vance and Ming Chen Hammond. These partnerships highlight the collaborative spirit of scientific research, bringing together diverse expertise to further advance the understanding of interferon biology and its applications.
Conclusion
Elie J Diner exemplifies the role of inventors in the realm of scientific advancement. His patent on cyclic di-nucleotide induction of type I interferon underscores the potential for innovation to drive significant therapeutic developments. As he continues his work at the University of California, the scientific community eagerly anticipates further contributions from this distinguished inventor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile